These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. Frequency and management of thrombocytopenia with the glycoprotein IIb/IIIa receptor antagonists. Huxtable LM; Tafreshi MJ; Rakkar AN Am J Cardiol; 2006 Feb; 97(3):426-9. PubMed ID: 16442410 [TBL] [Abstract][Full Text] [Related]
33. Platelet receptor glycoprotein IIb/IIIa inhibition with eptifibatide in a patient with thrombocytopenia after treatment with abciximab. Coto H J Invasive Cardiol; 2000 Oct; 12(10):528-31. PubMed ID: 11022214 [TBL] [Abstract][Full Text] [Related]
34. A randomized trial assessing the impact of three different glycoprotein IIb/IIIa antagonists on glycoprotein IIb/IIIa platelet receptor inhibition and clinical endpoints in patients with acute coronary syndromes. Holmes LE; Gupta R; Rajendran S; Luu J; French JK; Juergens CP Cardiovasc Ther; 2016 Oct; 34(5):330-6. PubMed ID: 27327862 [TBL] [Abstract][Full Text] [Related]
35. Care of the patient receiving ReoPro following angioplasty. Brezina K; Murphy M; Stonner T J Invasive Cardiol; 1994; 6 Suppl A():38A-42A; discussion 54A-56A. PubMed ID: 10155094 [No Abstract] [Full Text] [Related]
36. [Acute profound thrombocytopenia associated with the use of abciximab: case report]. Álvarez-Camarena B; Frutos-Rangel E; Rico-Curiel E; García-y Otero JM; Frutos-Rodríguez E Arch Cardiol Mex; 2011; 81(4):317-21. PubMed ID: 22188887 [TBL] [Abstract][Full Text] [Related]
37. Diminished expression of β2-GPI is associated with a reduced ability to mitigate complement activation in anti-GPIIb/IIIa-mediated immune thrombocytopenia. Zhu X; Zhang J; Wang Q; Fu H; Chang Y; Kong Y; Lv M; Xu L; Liu K; Huang X; Zhang X Ann Hematol; 2018 Apr; 97(4):641-654. PubMed ID: 29350259 [TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb/IIIa monoclonal antibody (7E3) in the rat: a quantitative rat model of immune thrombocytopenic purpura. Hansen RJ; Balthasar JP J Pharmacol Exp Ther; 2001 Jul; 298(1):165-71. PubMed ID: 11408538 [TBL] [Abstract][Full Text] [Related]
39. Identification of human platelet glycoprotein VI-specific IgG autoantibody and its fragments. Chu X; Hou M; Peng J; Zhu Y; Zhang F; Ji X; Wang L; Ma D Blood Coagul Fibrinolysis; 2006 Jul; 17(5):403-7. PubMed ID: 16788317 [TBL] [Abstract][Full Text] [Related]
40. The role of glycoprotein IIb/IIIa inhibition in the management of acute coronary syndromes. Koller CF Heart Lung; 2001; 30(5):321-9; quiz 330-1. PubMed ID: 11604974 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]